Correlation Between Abbott Laboratories and SCANDMEDICAL SOLDK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and SCANDMEDICAL SOLDK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and SCANDMEDICAL SOLDK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abbott Laboratories and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Abbott Laboratories and SCANDMEDICAL SOLDK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of SCANDMEDICAL SOLDK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and SCANDMEDICAL SOLDK.

Diversification Opportunities for Abbott Laboratories and SCANDMEDICAL SOLDK

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Abbott and SCANDMEDICAL is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with SCANDMEDICAL SOLDK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and SCANDMEDICAL SOLDK go up and down completely randomly.

Pair Corralation between Abbott Laboratories and SCANDMEDICAL SOLDK

Assuming the 90 days trading horizon Abbott Laboratories is expected to generate 0.66 times more return on investment than SCANDMEDICAL SOLDK. However, Abbott Laboratories is 1.51 times less risky than SCANDMEDICAL SOLDK. It trades about -0.12 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about -0.52 per unit of risk. If you would invest  11,204  in Abbott Laboratories on September 23, 2024 and sell it today you would lose (238.00) from holding Abbott Laboratories or give up 2.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Abbott Laboratories  vs.  SCANDMEDICAL SOLDK 040

 Performance 
       Timeline  
Abbott Laboratories 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Abbott Laboratories may actually be approaching a critical reversion point that can send shares even higher in January 2025.
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Abbott Laboratories and SCANDMEDICAL SOLDK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abbott Laboratories and SCANDMEDICAL SOLDK

The main advantage of trading using opposite Abbott Laboratories and SCANDMEDICAL SOLDK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, SCANDMEDICAL SOLDK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK will offset losses from the drop in SCANDMEDICAL SOLDK's long position.
The idea behind Abbott Laboratories and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas